http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019213508-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ceb2504c8d821ee1e5dd0861abee6d7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_888c17427537b9cb8c9a63f20631067b |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6827 |
filingDate | 2018-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67a8f3a6438cc4fded72c39b9c84d015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_581e5fb8aee75bae421ac433238c5e3d |
publicationDate | 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2019213508-A |
titleOfInvention | Trastuzumab side effect determination method and kit therefor |
abstract | A gene polymorphism associated with a side effect of trastuzumab is identified, and a side effect of trastuzumab is predicted using the polymorphism. A subject is analyzed for a gene polymorphism identified by rs139944387 or a gene polymorphism in linkage disequilibrium or genetic linkage with the gene polymorphism, and the genotype of the gene polymorphism is determined. The side effects of trastuzumab administration are determined based on the genotype obtained. [Selection figure] None |
priorityDate | 2018-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.